CRISPR-Cas systems, defense systems in bacteria, have become a plentiful source of technologies for molecular diagnostics.
Study offers insights into who’s at risk for long COVID among immunocompromised patients
Early in the pandemic, clinicians noticed that certain immunocompromised patients were experiencing persistent SARS-CoV-2 infections, some lasting weeks to months at a time.